Brannan Jamie 4

What Happened
Jamie Brannan, Executive Vice President of Zoetis Inc. (ZTS), was granted two awards of restricted stock units (RSUs) on February 18, 2026: 5,399 RSUs and 21,361 RSUs, for a total of 26,760 RSUs. The Form 4 lists these as derivative grants with an acquisition price of $0 (typical for RSU awards); no cash was paid by the insider. These RSUs represent a contingent right to receive shares of Zoetis common stock upon vesting.

Key Details

• Transaction date: 2026-02-18; Form 4 filed: 2026-02-19 (timely filing for the reported transaction).
• Grants: 5,399 RSUs and 21,361 RSUs (total 26,760 RSUs). Reported acquisition price: $0 (derivative grant).
• Vesting: Per filing footnotes, each RSU vests one-third on the first, second and third anniversaries of the grant date (first vesting anniversary = Feb 18, 2027). Dividend equivalent units are automatically issued on the RSUs.
• Shares owned after transaction: Not disclosed in the provided filing details.
• Footnotes: F1 = RSUs (including dividend equivalents); F3 = one‑third annual vesting schedule starting Feb 18, 2026.
• No sale or exercise reported — this is a grant/award (transaction code A).

Context
RSU grants are a common form of executive compensation and typically reflect retention/incentive programs rather than an immediate market view by the insider. These RSUs convert to actual shares only as they vest; there was no cash purchase or immediate sale reported. For retail investors, grants can be noteworthy but do not equate to an insider buying shares on the open market.